250
acute ischemic stroke patients
40 SITES
from US and New Zealand
CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.
SUMMIT MAX Clinical Trial
Transforming Intervention
Featuring the Monopoint® Reperfusion System
The SUMMIT MAX trial is currently underway to evaluate the safety and effectiveness of the Monopoint® Reperfusion System. The platform was designed to streamline delivery and enable super-bore aspiration at the most common stroke targets.
Landmark Clinical Trial
A RANDOMIZED, CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE ROUTE 92 MEDICAL REPERFUSION SYSTEM (SUMMIT MAX)
Randomized, Controlled trial
Primary endpoints
Effectiveness
Proportion of subjects with successful revascularization defined as a modified Thrombolysis in Cerebrovascular Infarction (mTICI) score of 2b or greater without adjunctive therapy.
Safety
Incidence of all symptomatic intracranial hemorrhage (sICH) within 24 hours post procedure.
Introducing the Monopoint® Reperfusion System
One Platform, One Point of Control
Unlike any other system, each component of the Monopoint® platform is designed to nest inside the next, providing a streamlined unit that can track through curvatures without catching side branches.
The telescoping design with tapered components:
- Designed to reduce ledge effect
- Allows for atraumatic movement through tortuous anatomy
- Advances from a
single point of control
- Engineered to bring consistent delivery through tortuous anatomy — often without a guidewire or crossing the clot
- Removes length constraints, ensuring compatibility with a broad range of therapeutic options
Large Bore, Minimal Effort
Balancing stability and flexibility, the Monopoint® platform allows you to deliver large (.070) and super-bore (.088) catheters to the distal M1.
Brings Together Base Camp® sheath, HiPoint™ Aspiration catheter & Tenzing® delivery catheter
Base Camp® Sheath:
Designed for Access & Stability
Provides access and a stable base for delivering large-bore and super-bore catheters from a single rotating hemostatic valve (RHV).
HiPoint™ 88 and HiPoint™ 70 Catheters:
Engineered for Enhanced Control
Hybrid design — engineered with a unique rail to reduce catheter-on-catheter friction and enhance operator control.
Tenzing® 7 and Tenzing® 8 Delivery Catheters:
Designed for Streamlined Navigation to the Target Site
Tapered, atraumatic tip designed to follow the natural flow of blood and seek the primary vessel.
Want to learn more? Email [email protected]
CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.